TCTR20240430003招募中1 期
The effectiveness of hydroquinone 4% versus hydroquinone 4% with intradermal injection of autologous platelet-rich plasma in the treatment of lichen planus pigmentosus: A comparative split-face clinical trial
Institute of Dermatology, Bangkok, Thailand0 个研究点目标入组 15 人开始时间: 2024年4月30日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1. Diagnosis of lichen planus pigmentosus of the face or neck in symmetrical distribution for 6 months or longer that has been confirmed by histopathology
- •2. Skin patch test negative for standard and extended series
排除标准
- •1. Pregnant or breastfeeding
- •2. Previous allergy to platelet-rich plasma
- •3. History of bleeding tendency, herpes infection at face or neck, and/or HIV or hepatitis B infection
- •4. Anti-oxidant supplements (e.g. vitamin C, vitamin E) in the past 3 months
- •5. Currently on chemotherapy and/or taking anti-coagulant medications
- •6. Laser treatment at face or neck in the past 3 months
- •7. Keloids or hypertrophic scars at the face or neck
- •8. Other skin diseases at injection sites for platelet-rich plasma at face or neck (e.g. infection, inflammation, neoplasm)
- •9. Participation in a clinical research study in the past 6 months
- •10. Oral isotretinoin, dapsone, or hydroxychloroquine during the past 3 months
- •11. Topical corticosteroids, topical calcineurin inhibitors, or topical skin lightening medication in the past 1 month
研究者
相似试验
已完成
3 期
Combination of Hydroquinone and Fractional CO2 Laser vs. Hydroquinone Monotherapy in Melasma Treatment: A Randomized Split-face Clinical TrialChloasmaIRCT20171222037987N1Esfahan University of Medical Sciences40
招募中
2 期
evaluating effectivness of Plasma rich in growth factor (PRGF) in the treatment of melasmaIRCT20221016056188N1Kerman University of Medical Sciences20
已完成
不适用
Efficacy of Hydroquinone 2% cream versus Tranexamic Acid InjectioIRCT2017040533244N1Deputy of Research and Technology of Shiraz University of Medical Sciences37
已完成
2 期
treatment of melasmamelasma.ChloasmaIRCT2014110919885N1Vice Chancellor for Researc?h, Hamadan university of medical science44
招募中
4 期
Comparative study between topical hydroquinone 4% alone versus its combination with intradermal autologous platelet-rich plasma in the treatment of melasma: a split-face controlled trialMelasmamelasma, autologous platelet-rich plasma, hydroquinoneTCTR20210925002Institute of Dermatology20